These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7217264)

  • 1. Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.
    Kuss HJ; Feistenauer E
    J Chromatogr; 1981 Jan; 204():349-53. PubMed ID: 7217264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of maprotiline and oxaprotiline in plasma by high-performance liquid chromatography of fluorescent derivatives.
    Breyer-Pfaff U; Wiatr R; Nill K
    J Chromatogr; 1984 Jul; 309(1):107-14. PubMed ID: 6480757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple inverse isotope dilution assay for the stereospecific quantitative determination of R(-) and S(+)-oxaprotiline in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1982 Jun; 242(2):289-97. PubMed ID: 6749873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorimetric determination of levoprotiline in human plasma after thin-layer chromatographic or high performance liquid chromatographic separation.
    Horne C; Spahn H; Mutschler E
    Arzneimittelforschung; 1987 Oct; 37(10):1179-81. PubMed ID: 3435591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected ion monitoring assay for the antidepressant maprotiline.
    Alkalay D; Carlsen S; Khemani L; Bartlett MF
    Biomed Mass Spectrom; 1979 Oct; 6(10):435-8. PubMed ID: 526561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLC-mass spectrometric determination of maprotiline and its major metabolite using stable isotope-labeled analog as internal standard.
    Jindal SP; Lutz T; Vestergaard P
    J Pharm Sci; 1980 Jun; 69(6):684-7. PubMed ID: 7205583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of maprotiline in serum by gas-chromatography, with use of a nitrogen-specific detector.
    Gupta RN; Molnar G; Gupta ML
    Clin Chem; 1977 Oct; 23(10):1849-52. PubMed ID: 902409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assay of maprotiline in biological fluids by gas-liquid chromatography.
    Geiger UP; Rajagopalan TG; Riess W
    J Chromatogr; 1975 Nov; 114(1):167-73. PubMed ID: 1184701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas chromatographic determination of maprotiline and its N-desmethyl metabolite in human blood using nitrogen detection.
    Sioufi A; Richard A
    J Chromatogr; 1980 Dec; 221(2):393-8. PubMed ID: 7217308
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of maprotiline and N-desmethylmaprotiline from biological fluids by HPLC.
    Salonen JS; Scheinin M
    J Anal Toxicol; 1983; 7(4):175-7. PubMed ID: 6632799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic separation of antidepressant drugs: II. Amoxapine and maprotiline.
    Beierle FA; Hubbard RW
    Ther Drug Monit; 1983; 5(3):293-301. PubMed ID: 6636257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatographic analysis of therapeutic concentrations of maprotiline in serum, using flame-ionization detection.
    Kärkkäinen S; Seppälä E
    J Chromatogr; 1980 Dec; 221(2):319-26. PubMed ID: 7217301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of amoxapine, 8-hydroxyamoxapine, and maprotiline by high-pressure liquid chromatography.
    Ketchum C; Robinson CA; Scott JW
    Ther Drug Monit; 1983; 5(3):309-12. PubMed ID: 6636258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas-liquid chromatographic procedure with alkali flame ionization detection for the determination of maprotiline in plasma.
    Charette C; McGilveray IJ; Midha KK
    J Chromatogr; 1981 Jun; 224(1):128-32. PubMed ID: 7263809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood concentrations of maprotiline in depressive patients].
    Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
    Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic fate of 14C-oxaprotiline X HCl in man. III. Stereospecific disposition.
    Dieterle W; Faigle JW; Küng W; Theobald W
    Biopharm Drug Dispos; 1984; 5(4):377-86. PubMed ID: 6525444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some observations on patient compliance in an antidepressive trial.
    Witts DJ; Mulgirigama D; Turner P; Pare CM
    Postgrad Med J; 1977; 53 Suppl 4():136-8. PubMed ID: 341102
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum levels of maprotiline and its adverse effects on depressed patients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):247-54. PubMed ID: 3437612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients.
    Hrdina PD; Lapierre YD
    Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).
    Miller PI; Beaumont G; Seldrup J; John V; Luscombe DK; Jones R
    J Int Med Res; 1977; 5 Suppl 4():101-11. PubMed ID: 590605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.